Thomas Graham, Alan, Irving Kahns - Kahn Brothers Group Investment Strategy & Portfolio Analysis

As of Mar 31, 2026, Thomas Graham, Alan, Irving Kahns's Kahn Brothers Group portfolio reflects a concentrated approach across 47 reported 13F positions. Portfolio returns are primarily driven by a small set of high-conviction positions such as Citigroup,, Bayer A.G., and NEW YORK COMMUNITY BANCORP, with the top five holdings accounting for approximately 52% of total exposure and Citigroup, alone contributing ~17%. While the portfolio includes 47 positions, economic outcomes are highly concentrated in a narrow set of healthcare and communication services names. Exposure to high-growth and technology-oriented segments remains limited relative to peers, with performance instead anchored in durable, cash-generating businesses across healthcare, communication services, and financials. The portfolio exhibits extremely low turnover, reinforcing a patient, conviction-led investment approach. Distinctive traits include Long-Term Holder, Structurally Diversified.